Stocks › BDX
Becton, Dickinson and Company (BDX) stock analysis
SKIP 11% confidence · analysed Sep 8, 2026
This analysis is from Sep 8, 2026 and may be out of date.
On Sep 8, 2026, our model rated Becton, Dickinson and Company (BDX) SKIP with 11% confidence at a price of $184.74. That means the signals cancel out; the model sees no clear edge either way.
Technical picture
The 14-day RSI is 55, showing healthy upward momentum without being stretched.
MACD is below its signal line, so short-term momentum is pointing down.
The price is above both its 50-day and 200-day moving averages, the classic picture of an uptrend.
Volume is about normal (0.9x the 20-day average).
Trend structure and money flow
Market structure: ranging / no clear structure.
The most recent swing high is $184.86 and the swing low is $140.11; traders often treat these as resistance and support.
Price is sitting in a bullish order block, a zone where large buyers stepped in before.
Fundamentals
The PEG ratio is 1.11, which looks reasonably priced for its growth.
The company reports a profit margin of 4.2% and revenue growth of +5.4%.
In its latest quarter it earned $3.23 per share, which beat the $3.14 analysts expected, with revenue +5.4% year over year.
Wall Street's average rating is 2.1 on a 1 (strong buy) to 5 (sell) scale, roughly a "buy", with an average price target of $195.67.
The next earnings report is expected around Nov 5, 2026; prices often move sharply around earnings.
The model's one-paragraph read
No clear edge (SKIP) — composite score +0.11 (SKIP). Technicals: RSI 55.42, MACD bearish, price above SMA50. Fundamentals: PEG 1.11, margin 4.2%, revenue growth 5.4%. Financial results: YoY revenue +5.4%, last EPS surprise +2.9%, next earnings 2026-11-05. Smart Money Concepts: ranging / no clear structure, price retesting a bullish order block, price retesting a bearish order block. FinGPT news read: positive. Reference price $179.38; no trade levels (SKIP).
Past ratings for BDX
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Sep 8, 2026 | SKIP | 11% | $184.74 | — |
"Move since" compares each call's price with the latest analysed price.
Other Healthcare stocks we cover
BIIB · BMY · BSX · CNC · COO · CVS · DVA · EVH · FTRE · HALO · HUM · IART
Frequently asked questions
Is BDX a buy right now?
As of Sep 8, 2026, our automated model rates Becton, Dickinson and Company (BDX) SKIP with 11% confidence: the signals cancel out; the model sees no clear edge either way. This is a model output for education, not personal investment advice.
When does Becton, Dickinson and Company report earnings next?
The next earnings report is expected around Nov 5, 2026.
What does a SKIP rating mean?
A SKIP rating means the signals cancel out; the model sees no clear edge either way.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.